Wang W, Wei PL, Lee YC, Huang MT, Chiu CC, Lee WJ. Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005;15:648–54. https://doi.org/10.1381/0960892053923752.
Abdelaal M, Le Roux CW, Docherty NG. Morbidity and mortality associated with obesity. Ann Transl Med. 2017;5:161. https://doi.org/10.21037/atm.2017.03.107.
Article PubMed PubMed Central Google Scholar
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. (2000) World Health Organ Tech Rep Ser.; 894:i-xii, 1-253. PMID: 11234459.
Bowman K, Atkins JL, Delgado J, Kos K, Kuchel GA, Ble A, Ferrucci L, Melzer D. Central adiposity and the overweight risk paradox in aging: follow-up of 130,473 UK Biobank participants. Am J Clin. Nutr. 2017;106:130–5. https://doi.org/10.3945/ajcn.116.147157.
Article CAS PubMed PubMed Central Google Scholar
Vyas V, Lambiase P. Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities. Arrhythm Electrophysiol Rev. 2019;8:28–36. https://doi.org/10.15420/aer.2018.76.2.
Article PubMed PubMed Central Google Scholar
Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, Soliman EZ, Maclehose R, Konety S, Alonso A. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the atherosclerosis risk in communities (ARIC) study. Circulation. 2011;123:1501–8. https://doi.org/10.1161/CIRCULATIONAHA.110.009035.
Article PubMed PubMed Central Google Scholar
Foy AJ, Mandrola J, Liu G, Naccarelli GV. Relation of Obesity to New-Onset Atrial Fibrillation and Atrial Flutter in Adults. Am J Cardiol. 2018;121:1072–5. https://doi.org/10.1016/j.amjcard.2018.01.019.
Wang TJ, Parise H, Levy D, D’Agostino RB, Wolf PA, Vasan RS, Benjamin EJ. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292:2471–7. https://doi.org/10.1001/jama.292.20.2471.
Article CAS PubMed Google Scholar
Wong CX, Sullivan T, Sun MT, Mahajan R, Pathak RK, Middeldorp M, Twomey D, Ganesan AN, Rangnekar G, Roberts-Thomson KC, Lau DH, Sanders P. Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC Clin Electrophysiol. 2015;1:139–52. https://doi.org/10.1016/j.jacep.2015.04.004.
Krijthe BP, Kunst A, Benjamin EJ, Lip GYH, Franco OH, Hofman A, Witteman JCM, Stricker BH, Heeringa J. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34:2746–51. https://doi.org/10.1093/eurheartj/eht280.
Article PubMed PubMed Central Google Scholar
Lee H, Choi EK, Lee SH, Han KD, Rhee TM, Park CS, Lee SR, Choe WS, Lim WH, Kang SH, Cha M-J, Oh S. Atrial fibrillation risk in metabolically healthy obesity: a nationwide population-based study. Int J Cardiol. 2017;240:221–7. https://doi.org/10.1016/j.ijcard.2017.03.103.
Cho B-H, Cheon K, Lee KY, Jung YH, Han SW, Park JH, Choi H-Y, Cho HJ, Park HJ, Nam HS, Heo JH, Lee HS, Kim S, Kim YD. Association between body mass index and stroke severity in acute ischaemic stroke with non-valvular atrial fibrillation. Eur J Neurol. 2020;27:1672–9. https://doi.org/10.1111/ene.14304.
Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS. Atrial fibrillation and obesity--results of a meta-analysis. Am Heart J. 2008;155:310–5. https://doi.org/10.1016/j.ahj.2007.10.004.
Frey WC, Pilcher J. Obstructive sleep-related breathing disorders in patients evaluated for bariatric surgery. Obes Surg. 2003;13:676–83. https://doi.org/10.1381/096089203322509228.
Qu YC, Du YM, Wu SL, Chen QX, Wu HL, Zhou SF. Activated nuclear factor-kappaB and increased tumor necrosis factor-alpha in atrial tissue of atrial fibrillation. ScandCardiovasc J. 2009;43:292–7. https://doi.org/10.1080/14017430802651803.
Venteclef N, Guglielmi V, Balse E, Gaborit B, Cotillard A, Atassi F, Amour J, Leprince P, Dutour A, Clément K, Hatem SN. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J. 2015;36:795–805a. https://doi.org/10.1093/eurheartj/eht099.
Article CAS PubMed Google Scholar
Balcioğlu AS, Çiçek D, Akinci S, Eldem HO, Bal UA, Okyay K, Müderrisoğlu H. Arrhythmogenic evidence for epicardial adipose tissue: heart rate variability and turbulence are influenced by epicardial fat thickness. Pacing Clin Electrophysiol. 2015;38:99e106. https://doi.org/10.1111/pace.12512.
Al Chekakie MO, Welles CC, Metoyer R, Ibrahim A, Shapira AR, Cytron J, Santucci P, Wilber DJ, Akar JG. Pericardial fat is independently associated with human atrial fibrillation. J Am CollCardiol. 2010;56:784–8. https://doi.org/10.1016/j.jacc.2010.03.071.
Martin K, Beyer-Westendorf J, Davidson BL, Huisman MV, Sandset PM, Moll S. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH. J ThrombHaemost. 2016;14:1308–13. https://doi.org/10.1111/jth.13323.
Yu L, Scherlag BJ, Sha Y, Li S, Sharma T, Nakagawa H, Jackman WM, Lazzara R, Jiang H, Po SS. Interactions between atrial electrical remodelling and autonomic remodelling: How to break the vicious cycle. Heart Rhythm. 2012;9:804–9. https://doi.org/10.1016/j.hrthm.2011.12.023.
Kaplan RM, Diaz CL, Strzelczyk T, You C, Saour B, Fine M, Trivedi A, Shen MJ, Sattayaprasert P, Chicos AB, Arora R, Kim S, Lin A, Verma N, Knight BP, Passman RS. Outcomes with novel oral anticoagulants in obese patients who underwent electrical cardioversion for atrial arrhythmias. Am J Cardiol. 2018;122:1175–8. https://doi.org/10.1016/j.amjcard.2018.06.022.
Article CAS PubMed PubMed Central Google Scholar
Thangjui S, Kewcharoen J, Yodsuwan R, Trongtorsak A, Thyagaturu H, Shrestha B, Winans ARM, Bischof E (2021) Efficacy and safety of direct oral anticoagulant in morbidly obese patients with atrial fibrillation: systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother.; pvab026. https://doi.org/10.1093/ehjcvp/pvab026.
Xue Y, Xu X, Zhang XQ, Farokhzad OM, Langer R. Preventing diet-induced obesity in mice by adipose tissue transformation and angiogenesis using targeted nanoparticles. Proc Natl AcadSci USA. 2016;113:5552–7. https://doi.org/10.1073/pnas.1603840113.
Iacobellis G, Mohseni M, Bianco SD, Banga PK. Liraglutide causes large and rapid epicardial fat reduction. Obesity. 2017;25:311–6. https://doi.org/10.1002/oby.21718.
Article CAS PubMed Google Scholar
Sato T, Aizawa Y, Yuasa S, Kishi S, Fuse K, Fujita S, Ikeda Y, Kitazawa H, Takahashi M, Sato M, Okabe M. The effect of dapagliflozin treatment on epicardial adipose tissue volume. Cardiovasc Diabetol. 2018;17:6. https://doi.org/10.1186/s12933-017-0658-8.
Article CAS PubMed PubMed Central Google Scholar
Chung MK, Eckhardt LL, Chen LY, Ahmed HM, Gopinathannair R, Joglar JA, Noseworthy PA, Pack QR, Sanders P, Trulock KM. Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association. Circulation. 2020;141:e750–72. https://doi.org/10.1161/CIR.0000000000000748.
Pathak RK, Elliott A, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Hendriks JML, Twomey D, Kalman JM, Abhayaratna WP, Lau DH, Sanders P. Impact of CARDIOrespiratoryFITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study. J Am CollCardiol. 2015;66:985–96. https://doi.org/10.1016/j.jacc.2015.06.488.
Qureshi WT, Alirhayim Z, Blaha MJ, Juraschek SP, Keteyian SJ, Brawner CA, Al-Mallah MH. Cardiorespiratory fitness and risk of incident atrial fibrillation: results from the Henry ford exercise testing (FIT) project. Circulation. 2015;131:1827–34. https://doi.org/10.1161/CIRCULATIONAHA.114.014833.
Jamaly S, Carlsson L, Peltonen M, Jacobson P, Sjöström L, Karason K. Bariatric surgery and the risk of new-onset atrial fibrillation in Swedish obese subjects. J Am Coll Cardiol. 2016;68:2497–504. https://doi.org/10.1016/j.jacc.2016.09.940.
Article PubMed PubMed Central Google Scholar
Donnellan E, Wazni OM, Kanj M, Baranowski B, Cremer P, Harb S, McCarthy CP, McEvoy JW, Elshazly MB, Aagaard P, Tarakji KG, Jaber WA, Schauer PR, Saliba WI. Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation. Europace. 2019;21:1476–83. https://doi.org/10.1093/europace/euz183.
Lévy S, Lauribe P, Dolla E, Kou W, Kadish A, Calkins H, Pagannelli F, Moyal C, Bremondy M, Schork A. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation. 1992;86:1415–20. https://doi.org/10.1161/01.CIR.86.5.1415.
Voskoboinik A, Moskovitch J, Plunkett G, Bloom J, Wong G, Nalliah C, Prabhu S, Sugumar H, Paramasweran R, McLellan A, Ling LH, Goh CY, Noaman S, Fernando H, Wong M, Taylor AJ, Kalman JM, Kistler PM. Cardioversion of atrial fibrillation in obese patients: Results from the Cardioversion-BMI randomized controlled trial. J Cardiovasc Electrophysiol. 2019;30:155–61. https://doi.org/10.1111/jce.13786.
Boehmer AA, Rothe M, Nussbaum E, Ruckes C, Dobre BC, Kaess BM, Ehrlich JR. Cryoballoon pulmonary vein isolation for atrial fibrillation in obese patients: A non-inferiority analysis. Int J Cardiol Heart Vasc. 2023;47:101244.
PubMed PubMed Central Google Scholar
Cha YM, Friedman PA, Asirvatham SJ, Shen WK, Munger TM, Rea RF, Brady PA, Jahangir A, Monahan KH, Hodge DO, Meverden RA, Gersh BJ, Hammill SC, Packer DL. Catheter ablation for atrial fibrillation in patients with obesity. Circulation. 2008;117:2583–90.
Lakkireddy DR, Blake GE, Patel D, Rotter M, Verma A, Ryschon K, Khan M, Schweikert R, Haissaguerre M, Natale A. Success of Radiofrequency Catheter Ablation of Atrial Fibrillation: Does Obesity Influence the Outcomes? J Atr Fibrillation. 2008;1:36.
Comments (0)